DIA 2013 49th Annual Meeting
Click here to go to the previous page
The Evolving Clinical Trial Disclosure Global Landscape
Track
:
Track 19: Communities Showcase
Program Code:
287
Date:
Tuesday, June 25, 2013
Time:
4:00 PM to 5:30 PM
EST
Location:
205B
CHAIR
:
SPEAKER
(S):
Jacqueline Cole, MS (SPKNON), Oncology Clinical Operations Portfolio Management, NA Clinical Operations, Eli Lilly and Company, United States
Jessica S. Scott, (SPKNON), GlaxoSmithKline, United States
Rebecca H. Li, PhD (SPKNON), Executive Director, Multi-Regional Clinical Trial (MRCT) Center, United States
Description
This session will present the current disclosure landscape, identify important global developments, discuss the potential impact that increased disclosure will have on clinical research, and identify how best to prepare for the future.
This session has been developed by the Clinical Trial Disclosure Community.
This session has been developed by the Clinical Trial Disclosure Community.
This session is a part of:
This session is a part of: